A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
Clinical trial NCT05610280 · COMPLETED
Trial details
- NCT number
- NCT05610280
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-21
- Primary completion
- 2024-08-08
- Enrollment
- 1478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.